Price
Target price
€3.16
€3.16
2.560%
0.08
2.560%
-
30.05.24 / Tradegate
WKN: A1XEDS / Symbol: EGRX / Name: Eagle Pharms / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Eagle Pharmaceuticals Inc Stock
There is an upward development for Eagle Pharmaceuticals Inc compared to yesterday, with an increase of €0.080 (2.560%).
Pros and Cons of Eagle Pharmaceuticals Inc in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
S********** s********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Eagle Pharmaceuticals Inc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Eagle Pharmaceuticals Inc | 2.560% | -8.671% | -17.708% | -84.040% | -29.464% | -90.424% | -93.299% |
Rockwell Medical Inc. | 1.120% | -1.333% | 19.691% | -33.646% | -6.055% | -78.600% | -96.307% |
Avid Bioservices Inc | -0.680% | -9.877% | 2.098% | -48.951% | 19.672% | -58.046% | 113.170% |
Gritstone Oncology Inc | -1.050% | -7.230% | -8.467% | -57.728% | -63.052% | -90.889% | - |
Comments
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) was downgraded by analysts at Piper Sandler from a "neutral" rating to an "underweight" rating.
Show more
Ratings data for EGRX provided by MarketBeat